Pimienta Medical Diagnostics is categorized under Health Services in Tucson, AZ and active since 2011.
Pimienta Medical Diagnostics was established in 2011, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Veronica Pimienta at the company’s single location by writing to 2330 North Rosemont Boulevard Unit B, Tucson, Arizona AZ 85712 or by phoning (520) 795-9300. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Pimienta Medical Diagnostics |
| Contact Person: | Veronica Pimienta |
| Address: | 2330 North Rosemont Boulevard Unit B, Tucson, Arizona 85712 |
| Phone Number: | (520) 795-9300 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Health Services |
| SIC Code: | 8099 |
| NAICS Code: | 6211110 |
| Share This Business: |
Pimienta Medical Diagnostics was started in 2011 to provide professional Health Services under the SIC code 8099 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Veronica Pimienta for inquiries that concern Pimienta Medical Diagnostics by calling the company number (520) 795-9300, as your correspondence is most welcome. Additionally, the physical location of the single location of Pimienta Medical Diagnostics can be found at the coordinates 32.24964,-110.88398 as well as the street address 2330 North Rosemont Boulevard Unit B in Tucson, Arizona 85712.
For its online presence, you may visit Pimienta Medical Diagnostics’s website at and engage with its social media outlets through on Twitter and on Facebook.